Garcia CD et al. |
Renal transplantation in children less than six years old. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750527
|
Gołębiewska J et al. |
Tako-tsubo cardiomyopathy on the first day after renal transplantation - case report and literature review. |
2014 |
Transplant. Proc. |
pmid:25380951
|
Risaliti A et al. |
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750569
|
Mendez R |
FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636522
|
Vanrenterghem Y et al. |
Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636523
|
Bilbao I et al. |
Indications and management of everolimus after liver transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715864
|
Corry RJ et al. |
Pancreas transplantation without antibody therapy. |
1998 |
Transplant. Proc. |
pmid:9532050
|
TuÄŸcu M et al. |
Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report. |
2015 |
Transplant. Proc. |
pmid:26093759
|
Kahl A et al. |
First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9532149
|
Charco R et al. |
A prospective, multicenter study of once-daily extended-release tacrolimus in de novo liver transplant recipients. |
2011 |
Transplant. Proc. |
pmid:21486582
|
Mueller AR et al. |
Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease. |
1994 |
Transplant. Proc. |
pmid:7527984
|
Suzuki K et al. |
Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy. |
2000 |
Transplant. Proc. |
pmid:11119910
|
Stock PG et al. |
Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. |
1993 |
Transplant. Proc. |
pmid:7679838
|
Abu-Elmagd KM et al. |
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721271
|
Sakr M et al. |
Effect of renal ischemia on plasma levels of FK 506 in rats. |
1992 |
Transplant. Proc. |
pmid:1371625
|
Smit JA et al. |
Induction of primate TH2 lymphokines to suppress TH1 cells. |
1996 |
Transplant. Proc. |
pmid:8623334
|
Hoffman AL et al. |
The effect of FK 506 on small intestine allotransplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1689907
|
Kaplinsky E et al. |
Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients. |
2012 |
Transplant. Proc. |
pmid:23146455
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|
Hachida M et al. |
Combined use of deoxyspergualin and FK 506 for temporary circulatory assist. |
1999 |
Transplant. Proc. |
pmid:10455968
|
MartÃn-Mateos RM et al. |
Initial immunosuppression with or without basiliximab: a comparative study. |
2012 |
Transplant. Proc. |
pmid:23146457
|
Barten MJ et al. |
Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. |
2005 |
Transplant. Proc. |
pmid:16387162
|
Nakamuta M et al. |
Cyclosporine suppresses cell growth and collagen production in hepatic stellate cells. |
2005 |
Transplant. Proc. |
pmid:16387179
|
Kim HC et al. |
Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center. |
2004 |
Transplant. Proc. |
pmid:15518753
|
Yeung S et al. |
Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15518754
|
Yoshimura N et al. |
Combination therapy of tacrolimus (FK506) with azathioprine and steroids in renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9474949
|
Fukushima N et al. |
Role of endothelial apoptosis in delayed xenograft rejection in pig-to-baboon cardiac transplantation. |
1999 |
Transplant. Proc. |
pmid:10578268
|
Kar S and Carr B |
Gene expression of FK 506-binding protein. |
1991 |
Transplant. Proc. |
pmid:1721303
|
Connelly PR |
Thermodynamics of interaction of FK 506-binding protein and its ligands. |
1991 |
Transplant. Proc. |
pmid:1721304
|
Metcalfe S et al. |
FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells. |
1990 |
Transplant. Proc. |
pmid:1697107
|
Lischke R et al. |
Initial single-center experience with sirolimus after lung transplantation. |
2006 |
Transplant. Proc. |
pmid:17112886
|
Moreno Gonzales M et al. |
Sublingual Tacrolimus in Liver Transplantation: A Valid Option? |
|
Transplant. Proc. |
pmid:27569953
|
Wang SS et al. |
Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus. |
2008 |
Transplant. Proc. |
pmid:18929814
|
Ennaifer R et al. |
Nodular hyperplasia of the gastrointestinal tract after liver transplantation: role of immunosuppressive therapy? A case report. |
2015 |
Transplant. Proc. |
pmid:25891739
|
Yang YJ et al. |
Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency. |
2008 |
Transplant. Proc. |
pmid:18589147
|
Benedini S et al. |
Glucose and leucine metabolism in lung tranplanted patients on low dose of steroids for immunosuppressive therapy. |
2008 |
Transplant. Proc. |
pmid:18589153
|
Grossi P et al. |
Infectious complications in experimental small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518155
|
Utsunomiya H et al. |
Effect of FK 506 on orthotopic small bowel transplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376521
|
Tsugita M et al. |
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. |
1995 |
Transplant. Proc. |
pmid:7533393
|
Izuishi K et al. |
Effect of an immunosuppressive agent, tacroliums (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems of rat liver microsomes. |
2003 |
Transplant. Proc. |
pmid:12591538
|
Kindt MV et al. |
Tacrolimus toxicity in rhesus monkey: model for clinical side effects. |
1999 |
Transplant. Proc. |
pmid:10616519
|
D'Alessandro AM et al. |
FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721335
|
Varo E et al. |
Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab. |
2002 |
Transplant. Proc. |
pmid:12176471
|
Braun F et al. |
Therapeutic drug monitoring of tacrolimus early after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176473
|
Braun F et al. |
How to handle mycophenolate mofetil in combination with tacrolimus? |
1998 |
Transplant. Proc. |
pmid:9865309
|
Schorlemmer HU et al. |
Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9865312
|
Wasiak D et al. |
Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report. |
2016 |
Transplant. Proc. |
pmid:27496507
|
Numakura K et al. |
Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919487
|
Ye Q et al. |
Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. |
1996 |
Transplant. Proc. |
pmid:8907895
|
Walgenbach KJ et al. |
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. |
1996 |
Transplant. Proc. |
pmid:8907896
|
De Ruvo N et al. |
Preliminary results of immunosuppression with thymoglobuline pretreatment and hepatitis C virus recurrence in liver transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182760
|
Rosh JR et al. |
Therapy with FK 506 in pediatric liver recipients. |
1994 |
Transplant. Proc. |
pmid:7509091
|
Kamei T et al. |
Established intraportal islet allograft is rejected despite the acceptance of donor-specific second cardiac allograft. |
1992 |
Transplant. Proc. |
pmid:1281579
|
Gregory CR |
Immunosuppressive approaches to the prevention of graft vascular disease. |
1998 |
Transplant. Proc. |
pmid:9595134
|
Woo J et al. |
FK 506 treatment following syngeneic bone marrow transplantation does not inhibit clonal deletion of V beta 5+ or V beta 11+ T cells. |
1992 |
Transplant. Proc. |
pmid:1281583
|
Offner G et al. |
FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up. |
1991 |
Transplant. Proc. |
pmid:1721366
|
Imai K et al. |
Histopathological study of canine pancreaticoduodenal allotransplantation with FK506, cyclosporine, and triple regimen immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703347
|
|
Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721367
|
Starzl TE et al. |
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. |
1991 |
Transplant. Proc. |
pmid:1703351
|
Gentil MA et al. |
Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age. |
2003 |
Transplant. Proc. |
pmid:12962766
|
Garcia I |
Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up. |
2002 |
Transplant. Proc. |
pmid:12176516
|
Hattori R et al. |
FK 506 in cadaveric kidney transplantation from non-heart-beating donors. |
1998 |
Transplant. Proc. |
pmid:9838666
|
Fischer L et al. |
Hepatitis G virus infection in liver transplant recipients. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083208
|
Nishioka T et al. |
Arterial stiffness after successful renal transplantation. |
2008 |
Transplant. Proc. |
pmid:18790249
|
Chien YS et al. |
Incidence and risk factors of new-onset diabetes mellitus after renal transplantation. |
2008 |
Transplant. Proc. |
pmid:18790250
|
Scott-Douglas N et al. |
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy. |
1996 |
Transplant. Proc. |
pmid:8962226
|
Suzuki H et al. |
Spleen grafting might induce transplantation tolerance in rats. |
1995 |
Transplant. Proc. |
pmid:7536973
|
Moutabarrik A et al. |
Use of FK 506 in kidney transplantation. |
1993 |
Transplant. Proc. |
pmid:7685946
|
Nakajima K et al. |
Effects of 15-deoxyspergualin and FK506 on the histology and survival of hamster-to-rat cardiac xenotransplantation. |
1989 |
Transplant. Proc. |
pmid:2468223
|
Kelly JS and Sharkey J |
Immunosuppressants-ligands as neuroprotectants. |
2001 |
Transplant. Proc. |
pmid:11377506
|
Akioka K et al. |
Diabetes in renal transplant recipients treated with tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176570
|
Mohacsi P et al. |
Immunosuppression in ABO-incompatible transplantation. |
2001 |
Transplant. Proc. |
pmid:11377508
|
Artz MA et al. |
Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels. |
2002 |
Transplant. Proc. |
pmid:12176579
|
Jonas S et al. |
Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy. |
2001 |
Transplant. Proc. |
pmid:11377511
|
Janezic AL et al. |
Alternatively spliced variants of IL-2 mRNA in sequential transplant kidney core needle biopsies. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266873
|
Opelz G |
New immunosuppressants and HLA matching. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266911
|
Fu F et al. |
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083555
|
Budde K et al. |
Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9723280
|
Wen J et al. |
Tripterygium wilfordii hook f increase the blood concentration of tacrolimus. |
2008 |
Transplant. Proc. |
pmid:19100464
|
Lorenzini S et al. |
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases. |
2006 |
Transplant. Proc. |
pmid:16797338
|
Langrehr JM et al. |
FK 506 inhibits nitric oxide production by cells infiltrating sponge matrix allografts. |
1991 |
Transplant. Proc. |
pmid:1721430
|
Hayakawa K et al. |
Maintenance of unresponsiveness by short-term pulse therapy with FK 506 in rat transplantation. |
1996 |
Transplant. Proc. |
pmid:8658904
|
Zeevi A et al. |
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. |
1987 |
Transplant. Proc. |
pmid:2445073
|
Asensio M et al. |
Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids. |
2002 |
Transplant. Proc. |
pmid:12176650
|
Sperschneider H |
A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267291
|
Dumortier J et al. |
Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience. |
2010 |
Transplant. Proc. |
pmid:20832553
|
Fukuoka N et al. |
Micafungin does not influence the concentration of tacrolimus in patients after allogeneic hematopoietic stem cell transplantation. |
2010 |
Transplant. Proc. |
pmid:20832577
|
Shapiro R |
Tacrolimus in solid organ transplantation: an update. |
1999 |
Transplant. Proc. |
pmid:10500545
|
Martins L et al. |
Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11134735
|
Hanack U et al. |
Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation? |
1998 |
Transplant. Proc. |
pmid:9723477
|
Morales J et al. |
Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells. |
2008 |
Transplant. Proc. |
pmid:19010240
|
Miyata Y et al. |
Development of xenogeneic microchimerism correlated with graft outcome in hamster-to-rat heart xenotransplantation. |
1998 |
Transplant. Proc. |
pmid:9723548
|
Valenzuela M et al. |
Early steroid withdrawal in pediatric renal transplantation at a single center: preliminary report. |
2008 |
Transplant. Proc. |
pmid:19010242
|
Aidong W et al. |
Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation. |
2004 |
Transplant. Proc. |
pmid:15561258
|
Bolton C |
The ability of myelin basic protein-sensitised leukocytes to adoptively transfer experimental allergic encephalomyelitis following coculture with FK 506, cyclosporine, or prednisolone. |
1991 |
Transplant. Proc. |
pmid:1721462
|
McManus BM et al. |
Impact of FK 506 on myocarditis in the enteroviral murine model. |
1991 |
Transplant. Proc. |
pmid:1721463
|
Nichelle L et al. |
Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-Neoral. |
2002 |
Transplant. Proc. |
pmid:12431623
|
Lo A et al. |
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267516
|
Soh KS et al. |
Simultaneous liver and kidney transplantation from different living donors. |
2012 |
Transplant. Proc. |
pmid:22410057
|
Morris RE et al. |
Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions. |
1991 |
Transplant. Proc. |
pmid:1703698
|